GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mettler-Toledo International Inc (NYSE:MTD) » Definitions » ROE %

Mettler-Toledo International (Mettler-Toledo International) ROE % : Negative Equity% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Mettler-Toledo International ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Mettler-Toledo International's annualized net income for the quarter that ended in Dec. 2023 was $739 Mil. Mettler-Toledo International's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $-128 Mil. Therefore, Mettler-Toledo International's annualized ROE % for the quarter that ended in Dec. 2023 was Negative Equity%.

The historical rank and industry rank for Mettler-Toledo International's ROE % or its related term are showing as below:

MTD' s ROE % Range Over the Past 10 Years
Min: 40.88   Med: 100.58   Max: Negative Equity
Current: Negative Equity

During the past 13 years, Mettler-Toledo International's highest ROE % was Negative Equity%. The lowest was 40.88%. And the median was 100.58%.

MTD's ROE % is ranked better than
99.54% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -6.13 vs MTD: Negative Equity

Mettler-Toledo International ROE % Historical Data

The historical data trend for Mettler-Toledo International's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mettler-Toledo International ROE % Chart

Mettler-Toledo International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 111.02 171.37 338.69 889.34 Negative Equity

Mettler-Toledo International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity 465,249.38 Negative Equity Negative Equity Negative Equity

Competitive Comparison of Mettler-Toledo International's ROE %

For the Diagnostics & Research subindustry, Mettler-Toledo International's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mettler-Toledo International's ROE % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mettler-Toledo International's ROE % distribution charts can be found below:

* The bar in red indicates where Mettler-Toledo International's ROE % falls into.



Mettler-Toledo International ROE % Calculation

Mettler-Toledo International's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=788.778/( (24.793+-149.938)/ 2 )
=788.778/-62.5725
=Negative Equity %

Mettler-Toledo International's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=739.176/( (-105.872+-149.938)/ 2 )
=739.176/-127.905
=Negative Equity %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Mettler-Toledo International  (NYSE:MTD) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=739.176/-127.905
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(739.176 / 3739.968)*(3739.968 / 3322.1425)*(3322.1425 / -127.905)
=Net Margin %*Asset Turnover*Equity Multiplier
=19.76 %*1.1258*N/A
=ROA %*Equity Multiplier
=22.25 %*N/A
=Negative Equity %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=739.176/-127.905
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (739.176 / 930.224) * (930.224 / 1054.792) * (1054.792 / 3739.968) * (3739.968 / 3322.1425) * (3322.1425 / -127.905)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7946 * 0.8819 * 28.2 % * 1.1258 * N/A
=Negative Equity %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Mettler-Toledo International ROE % Related Terms

Thank you for viewing the detailed overview of Mettler-Toledo International's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mettler-Toledo International (Mettler-Toledo International) Business Description

Traded in Other Exchanges
Address
1900 Polaris Parkway, Columbus, OH, USA, 43240
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences, industrial, and food retail industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with sales distribution roughly as follows: United States around 30% of sales, Europe around 30%, China around 20%, and the rest of the world around 20%.
Executives
Roland D Diggelmann director 3950 SOUTH COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Wolfgang Wienand director IM LANGACHER 44, GREIFENSEE V8 8606
Gerry Keller officer: Head of Process Analytics 1900 POLARIS PKWY, COLUMBUS OH 43240
Wong Ann Ping Richard officer: Head of Asia/Pac Market Orgs IM LANGACHER 44, GREIFENSEE V8 8606
Shawn Vadala officer: Chief Financial Officer 1900 POLARIS PKWY, COLUMBUS OH 43240
Wah-hui Chu director IM LANGACHER, GREIFENSEE V8 8606
Oliver A Filliol director METTLER TOLEDO INTL INC, IM LANGACHER 44, GREIFENSEE V8 8606
Christian Magloth officer: Head of Human Resources IM LANGACHER, GREIFENSEE V8 8608
Robert F Spoerry director METTLER TOLEDO INTL INC, IM LANGACHER, GREIFENSEE V8 99999
Peter Aggersbjerg officer: Head of Divisions & Operations 1900 POLARIS PKWY, COLUMBUS OH 43240
Ingrid Zhang director IM LANGACHER 44, GREIFENSEE V8 8606
De La Guerroniere Marc officer: Head of Eur & NA Market Orgs IM LANGACHER, GREIFENSEE V8 8606
Elisha W Finney director C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Michael A Kelly director 1900 POLARIS PKWY, COLUMBUS OH 43240
Patrick Kaltenbach officer: President and CEO IM LANGACHER 44, GREIFENSEE V8 8606